Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Scandinavian journal of respiratory diseases

• Publication date

  1977-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 404701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel.

  2009cited by this paper
• The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods.

  2009cited by this paper
• Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.

  2009cited by this paper
• The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. II. Comparison of the antibody response in man against thirteen O groups of Ps. aeruginosa.

  2009cited by this paper
• The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. V. Thermostability, resistance to degradation by plasmin activity and storage conditions of a polyvalent P. aeruginosa reference standard-antigen.

  2009cited by this paper
• The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. III. Reproducibility of a polyvalent P. aeruginosa reference standard-antigen.

  2009cited by this paper
• The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. I. Comparison of thirteen O groups of Ps. aeruginosa, with a polyvalent Ps. aeruginosa antigen-antibody reference system.

  2009cited by this paper
• Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

  2009cited by this paper
• Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification.

  2009cited by this paper
• The systematic evaluation of the chest radiograph in cystic fibrosis

  2005cited by this paper
• Haemophilus from the lower respiratory tract of patients with cystic fibrosis.

  1976cited by this paper
• Serological types of Diplococcus pneumoniae isolated from the respiratory tract of children with cystic fibrosis and children with other diseases.

  1976cited by this paper
• Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.

  1975cited by this paper
• Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.

  1975cited by this paper
• Staphylococcus aureus in cystic fibrosis: antibiotic sensitivity and phage types during the latest decade. Investigation of the occurrence of protein A and some other properties of recently isolated strains in relation to the occurrence of precipitating antibodies.

  1975cited by this paper
• Light and immunofluorescent study of the Arthus reaction in the rabbit lung.

  1975cited by this paper
• Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.

  1974cited by this paper
• PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS: Occurrence of Precipitating Antibodies against Pseudomonas Aeruginosa in Relation to the Concentration of Sixteen Serum Proteins and the Clinical and Radiographical Status of thi Lungs

  1974cited by this paper
• Serological typing of Pseudomonas aeruginosa and several points to be considered.

  1974cited by this paper
• Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.

  1974cited by this paper
• Bacterial Flora of Respiratory Tract in Patients with Cystic Fibrosis, 1950-1971

  1972cited by this paper
• Bacterial Infection in Cystic Fibrosis

  1972cited by this paper
• Pseudomonas aeruginosa: Immune Status in Patients with Cystic Fibrosis

  1972cited by this paper
• Pathogenesis and physiopathology of cystic fibrosis of the pancreas. Fibrocystic disease of the pancreas (Mucoviscidosis).

  1967cited by this paper
• [Research on O-antigens of Pseudomonas aeruginosa].

  1957cited by this paper

• Pseudomonas From Extreme Environments: Physiological and Molecular Adaptations

  2025cites this paper
• Antibody-guided identification of Achromobacter xylosoxidans protein antigens in cystic fibrosis

  2025cites this paper
• A comprehensive study on the dual species biofilm formation of clinical Staphylococcus aureus and Candida albicans strains from the same origins

  2025cites this paper
• Immune system dynamics in response to Pseudomonas aeruginosa biofilms

  2025cites this paper
• Combined Forces Against Bacteria: Phages and Antibiotics

  2025cites this paper
• Planktonic Aggregation Enhances Antibiotic Tolerance in Non-MDR Acinetobacter baumannii

  2025cites this paper
• Genomic and metabolic versatility of Pseudomonas aeruginosa contributes to its inter-kingdom transmission and survival.

  2024cites this paper
• Role of small molecules and nanoparticles in effective inhibition of microbial biofilms: A ray of hope in combating microbial resistance.

  2024cites this paper
• Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response

  2024cites this paper
• Cystic fibrosis and the clinical biofilm revolution A survey of the Danish CF Center's contribution

  2024cites this paper
• Staphylococcal mastitis in dairy cows

  2024cites this paper
• Monitoring cystic fibrosis airway infections with Pseudomonas aeruginosa with anti-OprF serum antibodies.

  2024cites this paper
• The non-attached biofilm aggregate

  2023cites this paper
• Eco-evolutionary dynamics of experimental Pseudomonas aeruginosa populations under oxidative stress

  2023cites this paper
• STRATEGIES TO APPLICATION OF PHENOTYPIC AND GENOTYPIC IDENTIFY PSEUDOMONAS AERUGINOSA

  2022cites this paper
• Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.

  2022cites this paper
• Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung

  2022cites this paper
• Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

  2022cites this paper
• Problems and achievements in the study of clinical and genetic aspects of cystic fibrosis

  2022cites this paper
• A review on biofilms and the currently available antibiofilm approaches: Matrix-destabilizing hydrolases and anti-bacterial peptides as promising candidates for the food industries.

  2022cites this paper
• Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis

  2022cites this paper
• Microbiome-derived antimicrobial peptides offer therapeutic solutions for the treatment of Pseudomonas aeruginosa infections

  2022cites this paper
• Immune Responses to Pseudomonas aeruginosa Biofilm Infections

  2021cites this paper
• Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  2021cites this paper
• NO donors and NO delivery methods for controlling biofilms in chronic lung infections

  2021cites this paper
• Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome

  2021cites this paper
• Peptidoglycan-Binding Anchor Is a Pseudomonas aeruginosa OmpA Family Lipoprotein With Importance for Outer Membrane Vesicles, Biofilms, and the Periplasmic Shape

  2021cites this paper
• Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatment

  2021cites this paper
• Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections

  2021cites this paper
• The Wsp intermembrane complex mediates metabolic control of the swim-attach decision of Pseudomonas putida

  2020cites this paper
• Biological evaluation of selected 1,2,3-triazole derivatives as antibacterial and antibiofilm agent.

  2020cites this paper
• Membrane-bound mucins of the airway mucosal surfaces are densely decorated with keratan sulfate: revisiting their role in the Lung's innate defense.

  2020cites this paper
• Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients

  2020cites this paper
• Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxo-dodecanoyl)-l-homoserine lactone triggers mitochondrial dysfunction and apoptosis in neutrophils through calcium signaling

  2019cites this paper
• The high persister phenotype ofPseudomonas aeruginosais associated with increased fitness and persistence in cystic fibrosis airways

  2019cites this paper
• Antibiotic resistance of bacterial biofilms 1 2 3

  2019cites this paper
• Evolutionary highways to persistent bacterial infection

  2019cites this paper
• Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical <named-content content-type='genus-species'>Pseudomonas aeruginosa</named-content> Biofilms

  2019cites this paper
• Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

  2019cites this paper
• Interaction of extracellular factors derived from Pseudomonas aeruginosa on keratinocytes

  2019cites this paper
• Luminescent Nanosensors for Ratiometric Monitoring of Three-Dimensional Oxygen Gradients in Laboratory and Clinical Pseudomonas aeruginosa Biofilms

  2019cites this paper
• Microbial biofilms and their impact on medical areas : physiopathology , diagnosis and treatment

  2018cites this paper
• Changing Rates of Chronic Pseudomonas aeruginosa Infections in Cystic Fibrosis: A Population-Based Cohort Study

  2018cites this paper
• Outer‐membrane protein LptD (PA0595) plays a role in the regulation of alginate synthesis in Pseudomonas aeruginosa

  2018cites this paper
• In vitro and ex vivo systems at the forefront of infection modeling and drug discovery

  2018cites this paper
• Prognostic factors in cystic fibrosis - the impact of antibody response and platelet activation

  2017influential citation
• The Role of Bacterial Biofi lms in Chronic Infections

  2017cites this paper
• Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis.

  2017cites this paper
• Anti-Infective Therapies in Cystic Fibrosis

  2017cites this paper
• Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis.

  2017cites this paper
• LIST OF PAPERS INCLUDED IN THIS THESIS I) Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia

  2017cites this paper
• Levofloxacin Inhalation Solution ( APT-1026 ) in Stable Cystic Fibrosis Patients

  2017cites this paper
• IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis.

  2017cites this paper
• Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis.

  2016cites this paper
• A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.

  2016cites this paper
• Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice

  2016cites this paper
• Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis

  2016cites this paper
• Epidemiology of Chronic Pseudomonas Lung Infections in Cystic Fibrosis Adolescents and Adults

  2015cites this paper
• Discrimination between bacterial species by ratiometric analysis of their carbohydrate binding profile

  2015cites this paper
• A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia.

  2015cites this paper
• Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis.

  2015cites this paper
• Clinical applications of pulmonary delivery of antibiotics.

  2015cites this paper
• Biofilm formation mechanisms and targets for developing antibiofilm agents.

  2015cites this paper
• A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.

  2015cites this paper
• Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)

  2014cites this paper
• Anti‐PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection

  2014cites this paper
• Early detection of infection with Pseudomonas aeruginosa in cystic fibrosis: the Holy Grail or an achievable goal?

  2014cites this paper
• The challenge of improving outcomes for patients with CF sinonasal disease.

  2014cites this paper
• Exhaled Breath Analysis Using Electronic Nose in Cystic Fibrosis and Primary Ciliary Dyskinesia Patients with Chronic Pulmonary Infections

  2014cites this paper
• Pseudomonas aeruginosa biofilms: mechanisms of immune evasion.

  2014cites this paper
• Pseudomonas aeruginosa Quorum-Sensing Molecule Homoserine Lactone Modulates Inflammatory Signaling through PERK and eI-F2α

  2014cites this paper
• Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis as a diagnostic tool: a systematic review.

  2014cites this paper
• eI-F2Inflammatory Signaling through PERK and Molecule Homoserine Lactone Modulates Quorum-Sensing Pseudomonas aeruginosa

  2014cites this paper
• Influence of O Polysaccharides on Outer Membrane Vesicle Formation and Biofilm Development in Pseudomonas aeruginosa PAO1

  2014cites this paper
• Pseudomonas aeruginosa biofilm infections: From molecular biofilm biology to new treatment possibilities

  2014cites this paper
• The role of two Pseudomonas aeruginosa anthranilate synthases in tryptophan and quorum signal production.

  2013cites this paper
• The role of bacterial biofilms in chronic infections

  2013cites this paper
• Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.

  2013cites this paper
• Antibacterial effect of silver coated carbon nanotubes against a mucoid strain of Pseudomonas aeruginosa

  2013cites this paper
• Applying insights from biofilm biology to drug development — can a new approach be developed?

  2013cites this paper
• Examining interactions between Pseudomonas aeruginosa and Staphylococcus aureus from cystic fibrosis lung infections

  2013cites this paper
• Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact.

  2013cites this paper
• Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes

  2013cites this paper
• Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment*

  2013cites this paper
• Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis

  2013cites this paper
• The infective pulmonary exacerbation in cystic fibrosis : an ecological perspective

  2013cites this paper
• Burkholderia cepacia. mucoid Pseudomonas aeruginosa and Microbial pathogenesis in cystic fibrosis

  2013cites this paper
• Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment* Infecção por Pseudomonas aeruginosa em pacientes com fibrose cística: evidências científicas sobre o impacto clínico, diagnóstico e tratamento*

  2013cites this paper
• Bacteria of the genus Dyella can chronically colonise the airways of patients with cystic fibrosis and elicit a pronounced antibody response.

  2013cites this paper
• Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen

  2012cites this paper
• Host Defence against Bacterial Biofilms: “Mission Impossible”?

  2012cites this paper
• Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution

  2012cites this paper
• The clinical impact of bacterial biofilms

  2011cites this paper
• Anti-quorum sensing, anti-bacterial, and immunomodulatory properties of Panax ginseng

  2011cites this paper
• Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.

  2011cites this paper
• Adaptive Immune Responses and Biofilm Infections

  2011cites this paper
• Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.

  2011cites this paper
• Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

  2011cites this paper
• Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection

  2011cites this paper
• Pseudomonas aeruginosa Biofilms in the Lungs of Cystic Fibrosis Patients

  2011cites this paper